Previous Blogs

NovaPure Sign

By West's Global Communications Team

August 09, 2016

This summer, West Pharmaceutical Services was delighted to exhibit at the 1st PDA Europe Annual Meeting. PDA organized this unique conference about the future of injectables to provide participants with a first-hand opportunity to gain deeper insight into current and future advances in modern sterile manufacturing and quality oversight. West also supported the NovaPure® 1-3 mL plunger launch during the meeting. Throughout the event, attendees were given the opportunity to engage with speakers, industry peers, regulators and exhibitors.

Blue West logo with Diamond

By Kevin Cancelliere

October 02, 2015

The current global market of prefilled syringes is comprised of over two billion units per year and growing. Many chronic diseases, such as multiple sclerosis and rheumatoid arthritis, require home-based administration of injectable therapies.

Unlocking Combinations Webinar

By West's Global Communications Team

May 06, 2015

How can your packaging and delivery system meet the requirements of the drug product, the expectations of the end user and the demands of regulatory agencies all at the same time?

Start with the end in mind.

Blue West logo with Diamond

By Tibor Hlobik

March 16, 2015

With more injectable biologics coming onto the market, and an increase in combination products, regulatory scrutiny is being given to the interaction between a drug product and its container closure system. If the right container closure and device are not selected for a biologic that is marketed in a prefilled syringe or auto-injector, there could be a significant impact on quality.